Literature DB >> 13678385

An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males.

Sławomir Dobrzycki1, Wojciech Serwatka, Sławomir Nadlewski, Janusz Korecki, Ryszard Jackowski, Janusz Paruk, Jerzy Robert Ladny, Tomasz Hirnle.   

Abstract

This clinical study investigated the possible associations of male sex hormone with the extensiveness of coronary artery lesions, coronary heart disease risk factors and ejection fraction of the heart. Ninety six Caucasian male subjects were recruited, 76 with positive and 20 with negative coronary angiograms. Early morning, prior to haemodynamic examination all of them had determined levels of total testosterone, free testosterone, free androgen index (FAI), sex hormone-binding globulin (SHBG), oestradiol, luteinizing hormone, follicle-stimulating hormone, plasma lipids, fibrinogen and glucose. The ejection fraction and the extensiveness of coronary lesions of each subject was assessed on the basis of x-ray examination results using Quantitative Coronary Angiography (QCA) and Left Ventricular Analysis (LVA) packages on the TCS Acquisition workstation, Medcon. Men with proven coronary heart disease had significantly lower levels of total testosterone (11.9 vs 21.2 nmol/l), free testosterone (45.53 vs 86.10 pmol/l), free androgen index (36.7 vs 47.3 IU) and oestradiol (109.4 vs 146.4 pmol/l). The level of testosterone was negatively associated with the DUKE Index. The most essential negative correlation was observed between SHBG and atherogenic lipid profile (low high-density lipoprotein, high triglycerides). Ejection fraction was substantially lower in patients (51.85 vs 61.30) (without prior myocardial infarction) with low levels of free-testosterone (23.85 vs. 86.10 pmol/l) and FAI (28.4 vs 47.3 IU). A negative correlation was observed between total testosterone, free testosterone, FAI and blood pressure, especially with diastolic pressure. Men with proven coronary atherosclerosis had lower levels of endogenous androgens than the healthy controls. For the first time in clinical settings it has been demonstrated that low levels of free-testosterone was characteristic for patients with low ejection fraction. Numerous hypothesies for this action can be proposed but all require a proper evaluation process. The main determinant of atherogenic plasma lipid was low levels of SHBG suggesting its main role in developing atheroscerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678385

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  10 in total

Review 1.  State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.

Authors:  Ahmed Elsherbiny; Matthew Tricomi; Digant Bhatt; Hari Kumar Dandapantula
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

2.  Androgenicity and venous endothelial function in post-menopausal women.

Authors:  M A Maturana; M C Rubira; F Consolim-Colombo; M C Irigoyen; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

Review 3.  Reactive oxygen species: players in the cardiovascular effects of testosterone.

Authors:  Rita C Tostes; Fernando S Carneiro; Maria Helena C Carvalho; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-04       Impact factor: 3.619

Review 4.  Vascular Pathways of Testosterone: Clinical Implications.

Authors:  Margarida Lorigo; Melissa Mariana; Nelson Oliveira; Manuel C Lemos; Elisa Cairrao
Journal:  J Cardiovasc Transl Res       Date:  2019-12-09       Impact factor: 4.132

Review 5.  Testosterone deficiency and cardiovascular mortality.

Authors:  Abraham Morgentaler
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

6.  Testosterone as a marker of coronary artery disease severity in middle aged males.

Authors:  Kunal Gururani; John Jose; Paul V George
Journal:  Indian Heart J       Date:  2016-08-08

7.  Does the serum testosterone level have a relation to coronary artery disease in elderly men?

Authors:  Mohamed A Helaly; Eid Daoud; Noha El-Mashad
Journal:  Curr Gerontol Geriatr Res       Date:  2011-05-23

8.  Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease.

Authors:  Carolyn M Webb; Andrew G Elkington; Mustafa M Kraidly; Niall Keenan; Dudley J Pennell; Peter Collins
Journal:  Am J Cardiol       Date:  2007-12-21       Impact factor: 2.778

Review 9.  Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.

Authors:  Peyman Mesbah Oskui; William J French; Michael J Herring; Guy S Mayeda; Steven Burstein; Robert A Kloner
Journal:  J Am Heart Assoc       Date:  2013-11-15       Impact factor: 5.501

Review 10.  Testosterone deficiency, cardiac health, and older men.

Authors:  G Hackett; M Kirby; A J Sinclair
Journal:  Int J Endocrinol       Date:  2014-04-10       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.